Detecting and analyzing severe pneumonia in critically ill patients
Official title: Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients
Run by Asan Medical Center · NCT01068990 · Data updated 2026-11-12
This study looks at patients in the ICU with severe pneumonia to see how different types of pneumonia affect their treatment and recovery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Asan Medical Center Academic / other |
| Locations | 1 site (Seoul) |
| Status | Recruiting |
| Started | March 2010 |
| Main results expected | February 28, 2028 |
| Study ends | February 28, 2028 |
| Registry record updated | October 28, 2026 |
| Trial ID | NCT01068990 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients admitted to the medical ICU with pneumonia or those who develop new pneumonia during their stay.
✕Probably not a fit
Patients who have been treated for pneumonia for more than 48 hours prior to ICU admission without an isolated causative organism may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on patients admitted to the medical intensive care unit (ICU) with severe pneumonia. It aims to monitor and analyze both community-acquired and hospital-acquired pneumonia, collecting data on patient demographics, clinical features, microbiological characteristics, and outcomes. The study will provide insights into the characteristics and treatment responses of critically ill patients suffering from lower respiratory infections.
Why it matters
Potential benefit: If successful, this study could improve the understanding and management of severe pneumonia in critically ill patients.
How similar studies have gone: Other studies have shown success in characterizing pneumonia in ICU settings, making this approach both relevant and tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients admitting medical ICU with pneumonia * Medical ICU admitted patients who is developed new pneumonia Exclusion Criteria: * Patients already treated more than 48 hours for pneumonia in transferring hospital and no causative organism is isolated
Where it's running
-
Asan Medical Center
Seoul, South Korea Recruiting
Study contacts
- Principal investigator: Sang-Ho Choi, MD — Asan Medical Center
- Study coordinator: Sang-Ho Choi, MD
- Email: sangho@amc.seoul.kr
- Phone: +82-2-3010-3304
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding the role of microbiomes in severe pneumonia
This study is trying to see how the bacteria in the lungs and gut affect how people with severe pneumonia get sick and recover.
-
High-dose vs standard-dose flu vaccine in adults with blood cancers on B-cell-depleting therapy
This study tests whether a high-dose flu shot evokes a stronger immune response than a standard-dose shot in adults with hematologic cancers who recently had B-cell-depleting therapy.
-
Videoconference Brief Cognitive Behavioral Therapy for mood disorders at high suicide risk
This study tests a short online CBT program to help people with mood disorders who are at high risk of suicide, and compares inflammatory biomarkers between groups.
-
AI-based prediction of five major diseases using integrated health data
Researchers are testing an AI model to see if they can predict the onset of five major diseases in adults 30–65 by combining medical records with biospecimens and lifestyle data.
-
Noninferiority test of a sirolimus-ascorbic acid stent vs everolimus stent in heart disease patients
This study tests whether a sirolimus-ascorbic acid eluting stent works as well as the standard everolimus-eluting stent for people with coronary artery disease undergoing PCI.
-
Blood Viscosity and Outcomes After Elective Brain Surgery
This study will test whether measures of blood viscosity taken during elective intracranial surgery relate to how patients recover and if they have postoperative complications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.